Literature DB >> 3893664

Sensorimotor perineuritis--an autoimmune disease?

C N Bourque, B A Anderson, C Martin del Campo, A A Sima.   

Abstract

The literature contains a single description of sensory perineuritis (Asbury et al 1972). These patients demonstrated a painful, distal, sensory neuropathy, and examination of peripheral nerve biopsies revealed focal thickening and inflammatory infiltrates of the perineurium. We report a patient with sensorimotor peripheral nerve dysfunction, accompanied by progressive slowing of nerve conduction velocity. Examination of a sural nerve biopsy demonstrated focal thickening of the perineurium, inflammatory infiltrates, and necrosis of perineurial cells. Immunohistology revealed a patchy precipitation of IgG and IgM on perineurial cells. Ultrastructurally, mononuclear cells were found adjacent to perineurial cells undergoing necrosis. The patient showed gradual improvement partially coinciding with a course of steroid therapy. We suggest that this neuropathy is caused by damage to the perineurial barrier possibly by an immune-mediated destruction of perineurial cells and subsequent compression of the endoneurial content by perineurial scarring.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893664     DOI: 10.1017/s0317167100046837

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  3 in total

1.  Long lasting recruitment of immune cells and altered epi-perineurial thickness in focal nerve inflammation induced by complete Freund's adjuvant.

Authors:  Geoffrey M Bove; Wendy Weissner; Mary F Barbe
Journal:  J Neuroimmunol       Date:  2009-06-28       Impact factor: 3.478

2.  Sensory perineuritis.

Authors:  W B Matthews; M V Squier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

3.  Perineuritis Successfully Treated with Early Aggressive Immunotherapy.

Authors:  Takumi Nakamura; Takeshi Kawarabayashi; Yusuke Seino; Mie Hirohata; Koichi Wakabayashi; Mikio Shoji
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.